Article Per Year (5 Year)
p-Index From 2019 - 2024
0.444
P-Index
This Author published in this journals
All Journal Radinka Journal of Health Science
Rasmala DEWI
Pharmacy Study Program, Sekolah Tinggi Ilmu Kesehatan Harapan Ibu, Jambi, Indonesia
Dentistry Health Professions Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
Evaluation of Good Medicine Distribution Methods (Cdob) and Implementation by Two Pharmaceutical Wholesalers (Pbf) in Jambi City Fahrinnisa Fahrinnisa Nabila PUTRI; Rasmala DEWI; Rifani Bhakti Natara
RADINKA JOURNAL OF HEALTH SCIENCE Vol. 1 No. 2 (2023): Radinka Journal of Health Science (RJHS)
Publisher : RADINKA JAYA UTAMA PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Pharmaceutical Wholesaler (PBF) is a company that distributes medicines to hospital installations, health centers, and pharmacies so that they can be given directly to patients or the public. One of the conditions that has been determined by existing regulations is that each PBF must have a Responsible Pharmacist who is responsible for implementing the provisions for procurement, storage, and distribution of medicines and/or medicinal substances. Good Medicine Distribution Method (CDOB) is the distribution of medicines or medicinal substances that have the aim of ensuring quality when distributing or dispensing medicines and medicinal substances so that they can be properly maintained under the requirements and intended use. Implementation of Good Medicine Distribution Methods at two PBFs, namely PBF X and Y, Jambi City. This research used a non-experimental descriptive design using questionnaires and direct interviews with the pharmacist in charge (APJ) and warehouse head. The results obtained by Good Medicine Distribution Methods from the 56-question PBF X and Y questionnaire fulfill the implementation of Good Medicine Distribution Methods. The research results obtained indicate that the percentage of PBF  
Evaluation of the Use of Antibiotics in Covid-19 Patients at X Muara Bulian Hospital in 2022 Yola Rizky Amalia; Rasmala DEWI; Deny SUTRISNO
RADINKA JOURNAL OF HEALTH SCIENCE Vol. 1 No. 3 (2024): Radinka Journal of Health Science (RJHS)
Publisher : RADINKA JAYA UTAMA PUBLISHER

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

Coronavirus Disease 2019 (COVID-19) is an infectious disease caused by Severe Acute Respiratory Syndrome Coronavirus2 (SARSCoV2). Treatment for COVID-19 is still uncertain, so various treatment efforts have been carried out, including administering antibiotics. This research is a type of non-experimental research and uses a descriptive research design. Data collection was carried out retrospectively. Data collection from medical records of COVID-19 patients in 2022 at Hospital X Muara Bulian. The population of 86 patients, a sample of 46 patients. The research results showed that 69.57% of patients were male, 32.61% of patients were aged 36–45 years, and Covid-19 patients received the most antibiotic therapy, namely azithromycin in the macrolide group at a dose of 500 mg for 5 days with a percentage of 69.57%, The accuracy of the indication, dose, and duration of administration of antibiotics is 100% following the COVID-19 Management Guidelines, Edition 2 of 2020, and no drug interactions have occurred. This research is based on existing literature. It is hoped that future researchers will use a larger sample size than this study so that they can understand demographic characteristics, patterns of antibiotic use, rational use of drugs, and drug interactions that occur.
Co-Authors Deny SUTRISNO Fahrinnisa Fahrinnisa Nabila PUTRI Rifani Bhakti Natara Yola Rizky Amalia